Loading…
AN2 Therapeutics, Inc. is projected to rise to $6.46 by 2027, a +39% move from its current price of $4.63. ANTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $4.44 | $4.63 | $4.83 | +0.02% |
| May 30 | $4.37 | $4.63 | $4.91 | +0.04% |
| May 31 | $4.31 | $4.63 | $4.98 | +0.06% |
| Jun 1 | $4.27 | $4.63 | $5.03 | +0.08% |
| Jun 2 | $4.23 | $4.63 | $5.08 | +0.10% |
| Jun 3 | $4.19 | $4.64 | $5.13 | +0.12% |
| Jun 4 | $4.16 | $4.64 | $5.17 | +0.14% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $4.16 | $4.64 | $5.17 | +0.14% |
| Week 2 | $3.98 | $4.64 | $5.42 | +0.29% |
| Week 3 | $3.85 | $4.65 | $5.62 | +0.43% |
| Week 4 | $3.74 | $4.66 | $5.79 | +0.58% |
| Week 5 | $3.66 | $4.66 | $5.95 | +0.73% |
| Week 6 | $3.58 | $4.67 | $6.10 | +0.87% |
| Week 7 | $3.51 | $4.68 | $6.24 | +1.02% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
AN2 Therapeutics, Inc. is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics.
Its initial candidate, epetraborole, is in phase-3 clinical trials as a once-daily oral treatment for non-tuberculous mycobacterial lung disease, and the company is studying it for acute melioidosis.
AN2 also develops AN2-502998 (AN15368), an investigational boron-based small molecule in preclinical trials for chronic Chagas disease, and conducts research programs targeting oncology and infectious disease based on its boron chemistry platform. It has license agreements with Anacor Pharmaceuticals, Brii Biosciences Limited, and GSK plc to support its development efforts, and was incorporated in 2017 with headquarters in Menlo Park, California.
AN2 Therapeutics, Inc. trades under the symbol ANTX and sits in the Healthcare category.
The current price is $4.85, and the market cap is $174.68M. The stock ranks 3921 by market capitalization.
The forecast path shows a near-term baseline with a 2026 average of $4.85, then rising toward longer-horizon targets: 2030 average $11.14 (ROI 129.8%), 2040 average $29.11 (ROI 500.1%), and 2050 average $79.28 (ROI 1534.7%), with sentiment described as BULLISH in the longer horizon.
Overall, these figures provide an outline of potential upside over the coming years, recognizing that forecasts are estimates and not guarantees.
A major floor 77.8% below — a decisive break under it would weaken the trend.
The nearest floor, 32.2% below — buyers have tended to step in here.
The nearest ceiling, 5.6% above — a clean break opens room to run.
A major ceiling 28.9% above — clearing it would confirm fresh momentum.
Key ANTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ANTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $4.74 | Sell | $4.70 | Sell |
| MA 10 | $4.64 | Sell | $4.66 | Sell |
| MA 20 | $4.63 | Buy | $4.53 | Buy |
| MA 50 | $4.08 | Buy | $4.00 | Buy |
| MA 100 | $2.87 | Buy | $3.25 | Buy |
| MA 200 | $2.02 | Buy | $2.54 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 55.10 | Neutral |
| Stoch RSI (14) | 23.84 | Neutral |
| CCI (20) | 0.82 | Neutral |
| Williams %R (14) | -41.94 | Info |
| MACD (12,26,9) | -0.03 | Sell |
| ROC (12) | 3.81 | Buy |
| Bollinger %B (20,2) | 0.50 | Neutral |
| Stochastic %K (14) | 58.06 | Neutral |
| TRIX (15) | 0.82 | Buy |
| Awesome (5,34) | 0.50 | Buy |
| Ultimate (7,14,28) | 48.48 | Neutral |
| Momentum (10) | 0.36 | Buy |
| Aroon Osc (25) | 88.00 | Buy |
| Hull MA (9) | 4.82 | Sell |
| ADX (14) | 19.91 | Neutral |
| ATR (14) | 0.16 | Info |
The near-term technical picture is bullish, with RSI(14) at 60. The stock trades above its SMA50 of $4.08 and well above its SMA200 of $1.99, indicating a constructive trend.
The 30-day range runs from $3.65 to $6.45, with a support level at $2.98 and a resistance at $4.89.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.03 | $4.63 | $7.09 | 0% | Neutral | |
| $4.87 | $6.46 | $9.20 | +39% | Bullish | |
| $6.67 | $9.24 | $13.84 | +100% | Bullish | |
| $7.86 | $11.29 | $17.59 | +144% | Bullish | |
| $7.42 | $11.02 | $17.74 | +138% | Bullish | |
| $8.25 | $12.64 | $20.94 | +173% | Bullish | |
| $8.78 | $13.84 | $23.52 | +199% | Bullish | |
| $8.59 | $13.93 | $24.21 | +201% | Bullish | |
| $10.72 | $17.84 | $31.67 | +285% | Bullish | |
| $13.31 | $22.72 | $41.14 | +391% | Bullish | |
| $15.20 | $29.28 | $57.45 | +532% | Bullish | |
| $36.44 | $80.98 | $178.23 | +16.5x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.03 | $4.63 | $5.50 | +0.00% |
| June 2026 | $3.93 | $4.67 | $5.72 | +0.90% |
| July 2026 | $3.92 | $4.72 | $5.89 | +0.99% |
| August 2026 | $4.17 | $5.07 | $6.42 | +7.37% |
| September 2026 | $4.23 | $5.18 | $6.65 | +2.25% |
| October 2026 | $4.03 | $4.98 | $6.46 | -3.89% |
| November 2026 | $4.07 | $5.06 | $6.63 | +1.67% |
| December 2026 | $4.29 | $5.37 | $7.09 | +6.03% |
Click any year to see its month-by-month ANTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ANTX to range from $1.03 to $7.09 through 2026. The $4.63 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ANTX price prediction for 2027 points to an average of $6.46 (low $4.87, high $9.20) — a potential gain of +39% on today's $4.63. Buyers look set to stay in control over this stretch.
In 2028, ANTX is projected to trade between $6.67 and $13.84, averaging $9.24 — a potential gain of +100% from today's $4.63. That is up +43% on the projected 2027 average. Momentum favours further upside here.
AN2 Therapeutics, Inc.'s 2029 outlook centres on $11.29, within a $7.86 to $17.59 range. That is up +22% on the projected 2028 average. That marks a +144% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ANTX could reach as high as $17.74, with a base case around $11.02 and support toward $7.42 — roughly +138% from $4.63. Momentum favours further upside here.
Expect ANTX to range from $8.25 to $20.94 through 2031. The $12.64 average target implies a +173% move from current prices. That is up +15% on the projected 2030 average. Buyers look set to stay in control over this stretch.
The ANTX price prediction for 2032 points to an average of $13.84 (low $8.78, high $23.52) — a potential gain of +199% on today's $4.63. Momentum favours further upside here.
In 2033, ANTX is projected to trade between $8.59 and $24.21, averaging $13.93 — a potential gain of +201% from today's $4.63. That is up +1% on the projected 2032 average. Buyers look set to stay in control over this stretch.
AN2 Therapeutics, Inc.'s 2034 outlook centres on $17.84, within a $10.72 to $31.67 range. That is up +28% on the projected 2033 average. That marks a +285% change versus current levels. Momentum favours further upside here.
By 2035, ANTX could reach as high as $41.14, with a base case around $22.72 and support toward $13.31 — roughly +391% from $4.63. Buyers look set to stay in control over this stretch.
Expect ANTX to range from $15.20 to $57.45 through 2040. The $29.28 average target implies a +532% move from current prices. That is up +29% on the projected 2035 average. Momentum favours further upside here.
The ANTX price prediction for 2050 points to an average of $80.98 (low $36.44, high $178.23) — a potential gain of +16.5x on today's $4.63. Buyers look set to stay in control over this stretch.
Investing $1,000 in ANTX today (≈ 215.982721 ANTX) could be worth
$17,489.81
+$16,489.81 (+1649%) by 2050 · US Dollar
Based on the average projected ANTX price of $80.98 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ANTXwould be worth at today's price.
$1,000 invested in ANTX on May 27, 2025 (≈ 847.457665 ANTX) would be worth
$3,923.73
+$2,923.73 (+292.4%) today · 3.92× · US Dollar
Based on a ANTX entry price of $1.18 vs. today's $4.63.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $4.59 | $1,008.71 | +0.9% |
| 1 month ago | $4.8 | $964.58 | -3.5% |
| 3 months ago | $1.06 | $4,367.92 | +336.8% |
| 6 months ago | $1.09 | $4,247.71 | +324.8% |
| 1 year ago | $1.18 | $3,923.73 | +292.4% |
| All time (4.2y) ago | $15.4 | $300.65 | -69.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ANTX forecast.
Our base-case forecast reaches $9.30 around 2029.
Implied market cap at $9.30: $334.95M
Over the multi-year forecast, the average price progresses from a 2026 forecast of $4.85 to higher targets: by 2030 the average is $11.14 with an ROI of 129.8% and a bullish sentiment; by 2040 the average is $29.11 with an ROI of 500.1% and a bullish sentiment; by 2050 the average is $79.28 with an ROI of 1534.7% and a bullish sentiment.
These figures imply a substantial long-run upside, but they are estimates and depend on numerous uncertain factors. The path reflects a shift toward stronger upside in later years, acknowledging inherent market and regulatory risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $11.14, with a range from $7.39 to $18.19 and an ROI of 129.8%, with bullish sentiment.
Forecasts show bullish sentiment in 2030, 2040, and 2050 with ROIs of 129.8%, 500.1%, and 1534.7% respectively, though the 2026 forecast is Neutral and these figures are estimates, not guarantees.
Yes. The 2040 forecast max is $58.25, which would exceed $40.
Current price is $4.85.
The 30-day range is $3.65 to $6.45.
AN2 Therapeutics, Inc. Community Discussion
0Share your AN2 Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.